ENGN enGene Holdings Inc.
Company Analysis
Latest News
🔴 enGene Holdings is trading 7% down in pre-market with no clear catalyst identified
enGene Holdings is trading at $1.60 (-7.01%) in pre-market, with no specific catalyst identified. - The company’s press-release page shows no recent release...
🟢 enGene Holdings is trading 7% up today as easing election uncertainty supports market rebound
enGene Holdings is trading 6.79% higher at $1.73, alongside broad market strength as easing election uncertainty supported a market rebound. - No clear...
🟢 enGene Holdings is trading 10.21% up today amid biotech-sector strength
enGene Holdings is trading at $1.60, up 10.21% on November 3, 2026, with broader biotech strength providing context for the move. - The biotech ETF XBI was up...
🟢 enGene Holdings is trading 5% up today amid biotech sector strength
enGene Holdings is trading at $1.52, up 5.17% on November 3, 2026; biotech-sector strength is the clearest available context, but is not confirmed as the...
🟢 enGene Holdings is trading 7.6% up in pre-market; no clear catalyst identified
enGene Holdings is trading at $1.56, up 7.59% in pre-market, with no clear catalyst established. - No company-specific announcement dated November 3 was...
🔴 enGene Holdings is trading 5% down amid broader biotech weakness
enGene Holdings is trading 5.23% down at $1.45, with biotech-sector weakness the strongest available context. - XBI is down 2.39% during the regular session...
🟢 enGene Holdings is trading 9.2% up in pre-market — catalyst remains unclear
enGene Holdings is trading up 9.15% at $1.67 in pre-market on October 30, 2026, as the reason for the move remains unclear. - No new company-specific...
🟢 enGene Holdings is trading 10.9% up in pre-market
enGene Holdings is trading at $1.73, up 10.90% in pre-market, with no clear company-specific or market catalyst identified. - No October 26 company-specific...
🟢 enGene Holdings is trading 5.5% up in pre-market as biotech ETF XBI rises 3.64%
enGene Holdings is trading at $1.72, up 5.52%, alongside biotech-sector strength; XBI was up 3.64% pre-market. - No new company-specific announcement...
🟢 enGene Holdings is trading 5% up today alongside a 2.10% XBI gain
enGene Holdings is trading at $1.66, up 5.06%, alongside a biotech-sector rally; no direct company-specific catalyst was identified. - No fresh...
🟢 enGene Holdings is trading 5.74% up in after-hours trading
enGene Holdings is trading 5.74% higher at $1.67 after-hours, with no clear company-specific catalyst identified. - It closed at $1.58 on October 19; its...
🔴 enGene Holdings is trading 5.5% down in after-hours trading with no clear catalyst identified
enGene Holdings is trading 5.5% lower at $1.62 after hours, with no clear company-specific catalyst identified. - It closed at $1.71 on October 15, then...
🟢 enGene Holdings is trading 6% up today amid biotech-sector gains
enGene Holdings is trading at $1.66, up 6.09%, with biotech-sector strength the clearest available context. - XBI is up 2.20% during regular trading. - No...
🟢 enGene Holdings is trading 5% up in pre-market with no clear catalyst identified
enGene Holdings is trading at $1.64, up 5.13% in pre-market, with no clear company-specific news explaining the rise. - enGene announced a KOL webinar for...